G.D. SEARLE LLC
Patent Owner
Stats
- 18 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 05, 2013 most recent publication
Details
- 18 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,009 Total Citation Count
- Apr 10, 1992 Earliest Filing
- 55 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE44048 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorderNov 14, 94Mar 05, 13[A61K]
RE43802 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsSep 21, 11Nov 13, 12[A61K]
RE43596 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsApr 23, 07Aug 21, 12[A61K, C07D]
RE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsApr 23, 07Nov 01, 11[A61K, C07D]
6410524 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular diseaseNov 05, 99Jun 25, 02[A61K]
6060476 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsMar 02, 94May 09, 00[A61K, C07D]
5968942 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsAug 23, 94Oct 19, 99[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredDec 07, 07Nov 09, 10[A61K]
7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredMay 15, 06May 12, 09[A61K, C07C]
2008/0281,084 Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorAbandonedApr 05, 07Nov 13, 08[C07K]
2008/0176,842 BIS-SULFONAMIDE HYDROXYETHYLAMINO RETROVIRAL PROTEASE INHIBITORSAbandonedNov 14, 07Jul 24, 08[A61K, C07D, C07C, A61P]
2008/0118,969 BIS-AMINO ACID HYDROXYETHYLAMINO SULFONAMIDE RETROVIRAL PROTEASE INHIBITORSAbandonedJan 29, 08May 22, 08[C12N]
7339078 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsExpiredAug 10, 06Mar 04, 08[C07C]
7320983 .alpha.- and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitorsExpiredSep 25, 06Jan 22, 08[A61K]
7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitorsExpiredFeb 08, 06Nov 20, 07[C07D]
7226757 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorExpiredJan 24, 06Jun 05, 07[C12P]
2007/0060,746 PROCESSES FOR PREPARATION OF 9,11 EPOXY STEROIDS AND INTERMEDIATES USEFUL THEREINAbandonedJul 21, 06Mar 15, 07[C07J]
2007/0015,818 Cyclic sulfone containing retroviral protease inhibitorsAbandonedJul 05, 06Jan 18, 07[A61K, C07D]
2006/0189,611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitorsAbandonedJan 24, 06Aug 24, 06[A61K, C07D]
7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorExpiredNov 30, 01Apr 04, 06[A61K]
7012094 Substituted furans and furanones for the treatment of inflammationExpiredApr 19, 95Mar 14, 06[A61K]
6890958 Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indicationsExpiredSep 18, 02May 10, 05[A61K, A01N]
2004/0176,438 Novel mono- and di-fluorinated beozothiepine copmunds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeAbandonedDec 23, 03Sep 09, 04[A61K, C07D]
2004/0110,761 Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disordersAbandonedJul 03, 03Jun 10, 04[A61K]
6740663 Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptakeExpiredNov 04, 02May 25, 04[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
